Almost a third of drugs cleared by the Food and Drug Administration pose safety risks that are identified only after their approval.
A research study published in January, 2017 set out to determine the impact of psychotropic medication use on the association between PTSD and the risk for dementia in a nationally representative sample of US veterans aged 56 years and older.
PTSD has become blurred as a catch-all diagnosis for some 175 combinations of symptoms, becoming the label for identifying the impact of adverse events on ordinary people. This means that normal responses to catastrophic events have often been fraudulently interpreted as mental disorders. The favored “treatment” for PTSD is psychotropic drugs known to cause violence and suicide.
In their study, researchers examined information from 3,139,780 veterans aged 56 and older.
“Researchers discovered that taking certain antidepressants, tranquilizers, sedatives, or antipsychotic medications significantly increased veterans’ risks for developing dementia compared to the risks for veterans who didn’t take such medications.”
The increase in the risk of dementia for veterans taking the drugs was the same whether or not they were diagnosed with PTSD.
Stated another way, patients diagnosed with PTSD using selective serotonin reuptake inhibitors, novel antidepressants, or antipsychotics were significantly more likely to be diagnosed with dementia compared to both those with and without a PTSD diagnosis but without any identified psychotropic medication use; and patients using benzodiazepines or serotonin-norepinephrine reuptake inhibitors appear to have an elevated risk for dementia diagnosis regardless of a PTSD diagnosis.
The bottom line seems to be that using psychiatric drugs increases one’s chance to develop dementia — one more reason that the first alternative to taking psychiatric drugs is just not taking them.
Click here for more information about the harm caused by psychiatric drugs.